How Our Protein Expression Services Drive Faster Assay and Drug Development
Introduction
From early target validation to assay development and preclinical testing, high-quality recombinant proteins are the foundation of modern drug development. But speed, reliability, and scalability are often lacking in traditional CRO workflows.
At RayBiotech, our protein expression services are designed to help translational scientists and drug developers get the proteins they need—on time, at scale, and in the format that fits their workflow. Whether you need small-scale research-grade protein for early R&D or milligram quantities of GMP protein for IND-enabling studies, we’ve built a system to accelerate assay development and streamline your preclinical journey.
Why Protein Expression Is a Drug Development Bottleneck
Producing a reliable, biologically active protein is harder than it sounds. Drug developers often struggle with:
- Delays from overburdened internal teams or unresponsive vendors
- Poor protein solubility or stability affecting assay performance
- Inconsistent expression yields that complicate lot-to-lot reproducibility
- Limited flexibility in scale (e.g., from microgram screening to gram-scale preclinical testing)
RayBiotech eliminates these pain points with end-to-end expression services that prioritize speed, flexibility, and assay-readiness.
